Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H30O16 |
Molecular Weight | 610.5175 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]5(OC[C@H]1O[C@@H](OC2=C(OC3=C(C2=O)C(O)=CC(O)=C3)C4=CC=C(O)C(O)=C4)[C@H](O)[C@@H](O)[C@@H]1O)O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O
InChI
InChIKey=IKGXIBQEEMLURG-NVPNHPEKSA-N
InChI=1S/C27H30O16/c1-8-17(32)20(35)22(37)26(40-8)39-7-15-18(33)21(36)23(38)27(42-15)43-25-19(34)16-13(31)5-10(28)6-14(16)41-24(25)9-2-3-11(29)12(30)4-9/h2-6,8,15,17-18,20-23,26-33,35-38H,7H2,1H3/t8-,15+,17-,18+,20+,21-,22+,23+,26+,27-/m0/s1
Molecular Formula | C27H30O16 |
Molecular Weight | 610.5175 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:02:14 UTC 2023
by
admin
on
Fri Dec 15 15:02:14 UTC 2023
|
Record UNII |
5G06TVY3R7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
120 (Number of products:1322)
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
||
|
WHO-ATC |
C05CA01
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
||
|
WHO-VATC |
QC05CA01
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
||
|
DSLD |
1394 (Number of products:104)
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
||
|
WHO-VATC |
QC05CA51
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
||
|
WHO-ATC |
C05CA51
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
||
|
NCI_THESAURUS |
C792
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
RUTIN
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
28527
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
100000090310
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
3535
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
153-18-4
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
5G06TVY3R7
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
205-814-1
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
61606
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
1606503
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
CHEMBL226335
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
5280805
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
SUB10407MIG
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
2213
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
D012431
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
DTXSID3022326
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
m9708
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | Merck Index | ||
|
5G06TVY3R7
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
4055
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
DB01698
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
C819
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | |||
|
9500
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY | RxNorm | ||
|
9220
Created by
admin on Fri Dec 15 15:02:14 UTC 2023 , Edited by admin on Fri Dec 15 15:02:14 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
SOLVATE->ANHYDROUS | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
CALENDULA OFFICINALIS FLOWER flavonoid
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Quantity of quercetin-3-glucuronide in urine of six healthy human subjects 0-24hr (total) after consumption of tomato juice containing 176 micromoles of rutin; Unit: nmoles
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Cmax: 4.3 +/- 1.5 nM; Tmax: 5.4 +/- 0.2 hr; T1/2: 6.9 +/- 0.3 hr (n=6)
IN-VIVO
PLASMA
|
||
|
METABOLITE -> PARENT |
IN-VIVO
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Quantity of Isorhamnetin-3-glucuronide in urine of six healthy human subjects 0-24hr (total) after consumption of tomato juice containing 176 micromoles of rutin; Unit: nmoles
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Cmax: 12 +/- 2 nM; Tmax: 4.7 +/- 0.3 hr; T1/2: 5.7 +/- 0.6 hr (n=6)
IN-VIVO
PLASMA
|
||
|
METABOLITE -> PARENT |
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Excretion of 3-Hydroxyphenylacetic acid in the urine of human subjects (n=6, 0-24hr total) after rutin (176 micromoles) supplemented tomato juice; Unit: micromoles
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Quantity of Quercetin-4'-glucuronide in urine of five healthy human subjects 0-24hr (total) after consumption of tomato juice containing 176 micromoles of rutin; Unit: nmoles
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Excretion of 3,4-Dihydroxyphenylacetic acid in the urine of human subjects (n=6, 0-24hr total) after rutin (176 micromoles) supplemented tomato juice; Unit: micromoles
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
IN-VIVO
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
Excretion of 3-Methoxy-4-Hydroxyphenylacetic acid in the urine of human subjects (n=6, 0-24hr total) after rutin (176 micromoles) supplemented tomato juice; Unit: micromoles
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
IN-VIVO
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
IN-VIVO
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
Quantity of Quercetin-3'-glucuronide in urine of six healthy human subjects 0-24hr (total) after consumption of tomato juice containing 176 micromoles of rutin; Unit: nmoles
IN-VIVO
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
NMT 2%
USP
|
||
|
IMPURITY -> PARENT |
USP
|
||
|
IMPURITY -> PARENT |
NMT 2%
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |